Advertisement

Multiple Primary Malignancies: “Non-codified” Associations

  • Alessandro Scotti
  • Alessandro Borrelli
  • Gioacchino Tedesco
  • Francesca Di Capua
  • Cristiano Cremone
  • Michele Giuseppe Iovino
  • Andrea Renda
Part of the Updates in Surgery book series (UPDATESSURG)

Abstract

A retrospective analysis of the most important international statistics on non-hereditary multiple tumors has demonstrated neoplastic associations (of unknown pathology) in which the appearance of a neoplasm in a determinate organ increases the risk of developing a second tumor in a “predefined” organ. Here we examine the most frequent associations, starting from an “index tumor” arising in a particular organ, and analyze the site and type of second and third tumors. The goal is to identify potential new syndromes as yet referred to as “not codified. ” Since colorectal tumors are dealt with in a separate chapter, only those neoplasms frequently observed by the department of General Surgery are considered in the following.

Keywords

Gastric Cancer Ovarian Cancer Esophageal Cancer Early Gastric Cancer Esophageal Carcinoma 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    The Research Group for Population-based Cancer Registration in Japan (2002) Cancer incidence and incidence rates in Japan in 1997: estimates based on data from 12 populationbased cancer registries. Jpn J Clin Oncol 32:318–322CrossRefGoogle Scholar
  2. 2.
    Taeger D, Sun Y, Keil U et al (2000) A stand-alone Windows application for computing exact person-years, standardized mortality ratios and confidence intervals in epidemiological studies. Epidemiology 11:607–608PubMedCrossRefGoogle Scholar
  3. 3.
    Bidoli P, Bajetta E, Stani SC et al (2002) Ten-year survival with chemotherapy and radiotherapy in patients with squamous cell carcinoma of the esophagus. Cancer 94:352–361PubMedCrossRefGoogle Scholar
  4. 4.
    Kumagai Y, Kawano T, Nakajima Y et al (2001) Multiple primary cancers associated with esophageal carcinoma. Surg Today 31:872–876PubMedCrossRefGoogle Scholar
  5. 5.
    Wind P, Roullet MH, Quinaux D et al (1999) Long-term results after esophagectomy for squamous cell carcinoma of the esophagus associated with head and neck cancer. Am J Surg 178:251–255PubMedCrossRefGoogle Scholar
  6. 6.
    Kumagai Y, Kawano T, Nakajima Y et al (2001) Multiple primary cancers associated with esophageal carcinoma. Surg Today 31:872–876PubMedCrossRefGoogle Scholar
  7. 7.
    Natsugoe S, Matsumoto M, Okumura H et al (2005) Multiple primary carcinomas with esophageal squamous cell cancer: clinicopathologic outcome. World J Surg 29:46–49PubMedCrossRefGoogle Scholar
  8. 8.
    Matsubara T, Yamada K, Nakagawa A (2003) Risk of second primary malignancy after esophagectomy for squamous cell carcinoma of the thoracic esophagus. J Clin Oncol 21:4336–4341PubMedCrossRefGoogle Scholar
  9. 9.
    Yasuda M, Kuwano H, Watanabe M et al (2000) P53 expression in squamous dysplasia associated with carcinoma of the oesophagus evidence for field carcinogenesis. Br J Cancer 83:1033–1038PubMedCrossRefGoogle Scholar
  10. 10.
    Matsubara T, Ueda M, Uchida C et al (2000) Modified stomach roll for safer reconstruction after subtotal esophagectomy. J Surg Oncol 75:214–216PubMedCrossRefGoogle Scholar
  11. 11.
    Lundegardh G, Hansson LE, Nyren O et al (1991) The risk of gastrointestinal and other primary malignant disease following gastric cancer. Acta Oncol 30:1–6PubMedCrossRefGoogle Scholar
  12. 12.
    Park YK, Kim DY, Joo JK et al (2005) Clinicopathological features of gastric carcinoma patients with other primary carcinomas. Langenbecks Arch Surg 390:300–305PubMedCrossRefGoogle Scholar
  13. 13.
    Ikeda Y, Saku M, Kishihara F, Maehara Y (2005) Effective follow-up for recurrence or a second primary cancer in patients with early gastric cancer. Br J Surg 92:235–239PubMedCrossRefGoogle Scholar
  14. 14.
    Bozzetti F, Bonfanti G, Mariani L et al (2000) Early gastric cancer: unrecognized indicator of multiple malignancies. World J Surg 24:583–587PubMedCrossRefGoogle Scholar
  15. 15.
    Yoshino K, Asanuma F, Hanatani Y et al (1985) Multiple primary cancers in the stomach and other organs: frequency and the effects on prognosis. Jpn J Clin Oncol 15:183–190PubMedGoogle Scholar
  16. 16.
    Kim SH, Min JS, Whang KC (1984) Multiple primary malignant tumors. J Korean Stat Soc 26:314–319Google Scholar
  17. 17.
    Ikeda Y, Saku M, Kawanaka H et al (2003) Features of second primary cancer in patients with gastric cancer. Oncology 65:113–117PubMedCrossRefGoogle Scholar
  18. 18.
    Sugiyama M, Atomi Y (1999) Extrapancreatic neoplasm occur with unusual frequency in patient with intraductal papillary mucinous tumors of the pancreas. Am J Gastroenterol 94:470–473PubMedCrossRefGoogle Scholar
  19. 19.
    Yamaguchi K, Yohohata K, Noshiro H et al (2000) Mucinous cystic neoplasm of the pancreas intraductal papillary-mucinous tumor of the pancreas. Eur J Surg 166:141–148PubMedCrossRefGoogle Scholar
  20. 20.
    Eguchi H, Ishikawa O, Ohigashi H et al (2006) Patients with pancreatic intraductal papillary mucinous neoplasm are at high risk of colorectal cancer development. Surgery 139(6):749–754PubMedCrossRefGoogle Scholar
  21. 21.
    Kamisawa T, Tu Y, Egawa N, Nakajima H (2005) Malignancies associated with intraductal papillary mucinous neoplasm of the pancreas. World J Gastroenterol 11(36):5688–5690PubMedGoogle Scholar
  22. 22.
    Eriguchi N, Aoyagi S, Hara M et al (2000) Synchronous or metachronous double cancer of the pancreas and other organs: report on 12 cases. Surg Today 30:718–721PubMedCrossRefGoogle Scholar
  23. 23.
    Dent SF, Klaassen D, Pater JL et al (2000) Second primary malignancies following the treatment of early stage ovarian cancer: update of a study by the National Cancer Institute of Canada-Clinical Trials Group (NCIC-CTG). Ann Oncol 11:65–68PubMedCrossRefGoogle Scholar
  24. 24.
    Escobar PF, Patrick R, Rybickiy L et al (2006) Primary gynecological neoplasms and clinical outcomes in patients diagnosed with breast carcinoma. Int J Gynecol Cancer 16(Suppl 1):118–122PubMedCrossRefGoogle Scholar
  25. 25.
    Takeda T, Sagae S, Koizumi M et al (1995) Multiple primary malignancies in patients with gynecologic cancer. Int J Gynecol Cancer 5:34–39PubMedCrossRefGoogle Scholar
  26. 26.
    Rozen P, Fireman Z, Figer A, Ron E (1986) Colorectal tumor screening in women with a past history of breast, uterine, or ovarian malignancies. Cancer 57(6): 1235–1239PubMedCrossRefGoogle Scholar
  27. 27.
    Corrao G, Zambon A, Conti V et al (2007) Menopause hormone replacement therapy and cancer risk: an Italian record linkage investigation. Ann Oncol 19(1): 150–155PubMedCrossRefGoogle Scholar
  28. 28.
    Takano K, Ichikawa Y, Ueno E et al (2005) Microsatellite instability and expression of mismatch repair genes in sporadic endometrial cancer coexisting with colorectal or breast cancer. Oncol Rep 13(1): 11–16PubMedGoogle Scholar
  29. 29.
    Werner-Wasik M, Schmid CH, Bornstein LE, Madoc-Jones H (1995) Increased risk of second malignant neoplasms outside radiation fields in patients with cervical carcinoma. Cancer 75(9):2281–2285PubMedCrossRefGoogle Scholar
  30. 30.
    Chaturvedi AK, Engels EA, Gilbert ES et al (2007) Second cancers among 104,760 survivors of cervical cancer: evaluation of long-term risk. J Natl Cancer Inst 99(21): 1634–1643PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Italia 2009

Authors and Affiliations

  • Alessandro Scotti
    • 1
  • Alessandro Borrelli
    • 1
  • Gioacchino Tedesco
    • 1
  • Francesca Di Capua
    • 1
  • Cristiano Cremone
    • 1
  • Michele Giuseppe Iovino
    • 1
  • Andrea Renda
    • 1
  1. 1.Surgical, Anesthesiology-rianimative and Emergency Sciences DepartmentFederico II UniversityNaplesItaly

Personalised recommendations